Did you know that osteoarthritis (OA) is a prevalent condition affecting nearly 40% of cats, leading to joint pain and reduced mobility?
Recognizing the need for effective pain management, Solensia™ (frunevetmab injection) has emerged as a groundbreaking treatment option.
What is Solensia?
Solensia is the first FDA-approved monoclonal antibody therapy specifically designed to manage osteoarthritis pain in cats. Administered as a once-monthly injection by a veterinarian, it targets Nerve Growth Factor (NGF), a key mediator in pain signaling. By inhibiting NGF, Solensia effectively reduces pain associated with OA, enhancing your cat’s comfort and mobility.
Benefits of Solensia
Convenient Administration: Given once a month by your veterinarian, eliminating the need for daily oral medications.
Improved Quality of Life: Many cat owners have observed significant enhancements in their cats’ activity levels and overall well-being following treatment.
Safety and Side Effects
Clinical studies have demonstrated Solensia’s safety profile. The most commonly reported side effects include mild and transient reactions such as vomiting, diarrhea, and injection site discomfort. It’s essential to discuss any concerns with your veterinarian to ensure the best care for your cat.
Is Solensia Right for Your Cat?
If your cat exhibits signs of osteoarthritis—such as decreased activity, difficulty jumping, or stiffness—consult your veterinarian. They can assess your cat’s condition and determine if Solensia is an appropriate treatment option.
Incorporating Solensia into your cat’s healthcare plan may provide the relief needed to maintain an active and comfortable life.
Pet Owner Resources
For more information, please visit: https://www.zoetispetcare.com/products/solensia
Feline Osteoarthritis Pain Quiz: https://www.zoetispetcare.com/products/solensia/quiz/cat-osteoarthritis